1-6 of 6
Rosemary L. Balleine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

Peter Fox, Rosemary L. Balleine, Clara Lee, Bo Gao, Bavanthi Balakrishnar, Alexander M. Menzies, Shang Heng Yeap, Sayed Sahanawaz Ali, Val Gebski, Pamela Provan, Sally Coulter, Christopher Liddle, Rina Hui, Richard Kefford, Jodi Lynch, Mark Wong, Nicholas Wilcken, Howard Gurney
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (13): 3164–3171.
https://doi.org/10.1158/1078-0432.CCR-15-1470
Published: 30 June 2016
View article titled, Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study
Open the PDF for Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study in another window
Includes: Supplementary data
Journal Articles

Abstract A25: BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.

Anna DeFazio, Tania Moujaber, Dariush Etemadmoghadam, Catherine Kennedy, Yoke-Eng Chiew, Rosemary L. Balleine, Catherine Saunders, Gerard V. Wain, Alexander Dobrovic, Australian Ovarian Cancer Study Group (AOCS), David DL Bowtell, Paul R. Harnett
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A25.
https://doi.org/10.1158/1557-3265.OVCA15-A25
Published: 15 January 2016
View article titled, Abstract A25: BRAFV600E mutations in serous ovarian cancer and response to the BRAF inhibitor, dabrafenib.
Journal Articles

Abstract A55: Influence of ABCB1 polymorphisms on paclitaxel pharmacokinetics in ovarian cancer patients

Bo Gao, Annemieke J.M. Nieuweboer, Hongmei Xu, Jonathan Beesley, Inge M. Ghobadi Moghaddam-Helmantel, Anne-Joy M. de Graan, Peter de Bruijn, Howard Gurney, Sharon E. Johnatty, Philip Beale, Georgia Chenevix-Trench, Rosemary L. Balleine, Ron H.J. Ron H.J. Mathijssen, Paul R. Harnett
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A55.
https://doi.org/10.1158/1078-0432.OVCA13-A55
Published: 13 May 2014
View article titled, Abstract A55: Influence of ABCB1 polymorphisms on paclitaxel pharmacokinetics in ovarian cancer patients
Journal Articles

Molecular Grading of Ductal Carcinoma In situ of the Breast

Rosemary L. Balleine, Lucy R. Webster, Sean Davis, Elizabeth L. Salisbury, Juan P. Palazzo, Gordon F. Schwartz, Dennis B. Cornfield, Robert L. Walker, Karen Byth, Christine L. Clarke, Paul S. Meltzer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8244–8252.
https://doi.org/10.1158/1078-0432.CCR-08-0939
Published: 15 December 2008
View article titled, Molecular Grading of Ductal Carcinoma <em>In situ</em> of the Breast
Open the PDF for Molecular Grading of Ductal Carcinoma <em>In situ</em> of the Breast in another window
Includes: Supplementary data
Journal Articles

Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer

Lyndee L. Scurr, Alexander D. Guminski, Yoke-Eng Chiew, Rosemary L. Balleine, Raghwa Sharma, Ying Lei, Kylie Pryor, Gerard V. Wain, Alison Brand, Karen Byth, Catherine Kennedy, Helen Rizos, Paul R. Harnett, Anna deFazio
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6924–6932.
https://doi.org/10.1158/1078-0432.CCR-07-5189
Published: 03 November 2008
View article titled, Ankyrin Repeat Domain 1, <em>ANKRD1</em>, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer
Open the PDF for Ankyrin Repeat Domain 1, <em>ANKRD1</em>, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer in another window
Journal Articles

Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification

Lucy R. Webster, Shu-Fen Lee, Clare Ringland, Adrienne L. Morey, Andrew M. Hanby, Graeme Morgan, Karen Byth, Patricia A. Mote, Pamela J. Provan, Ian O. Ellis, Andrew R. Green, Gillian Lamoury, Peter Ravdin, Christine L. Clarke, Robyn L. Ward, Rosemary L. Balleine, Nicholas J. Hawkins
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6625–6633.
https://doi.org/10.1158/1078-0432.CCR-08-0701
Published: 16 October 2008
View article titled, Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
Open the PDF for Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification in another window
Includes: Supplementary data